Abstract
The c.156_157insAlu BRCA2 mutation has so far only been reported in hereditary breast/ovarian cancer (HBOC) families of Portuguese origin. Since this mutation is not detectable using the commonly used screening methodologies and must be specifically sought, we screened for this rearrangement in a total of 5,443 suspected HBOC families from several countries. Whereas the c.156_157insAlu BRCA2 mutation was detected in 11 of 149 suspected HBOC families from Portugal, representing 37.9% of all deleterious mutations, in other countries it was detected only in one proband living in France and in four individuals requesting predictive testing living in France and in the USA, all being Portuguese immigrants. After performing an extensive haplotype study in carrier families, we estimate that this founder mutation occurred 558 ± 215 years ago. We further demonstrate significant quantitative differences regarding the production of the BRCA2 full length RNA and the transcript lacking exon 3 in c.156_157insAlu BRCA2 mutation carriers and in controls. The cumulative incidence of breast cancer in carriers did not differ from that of other BRCA2 and BRCA1 pathogenic mutations. We recommend that all suspected HBOC families from Portugal or with...Continue Reading
References
Jun 1, 1994·Nature Genetics·G GyapayJ Weissenbach
Apr 29, 1998·American Journal of Human Genetics·D FordM Zelada-Hedman
Jul 20, 2001·Human Mutation·B Rannala, G Bertorelle
Aug 10, 2005·Human Mutation·Erik TeugelsJacques De Grève
Jul 11, 2006·Familial Cancer·Ana PeixotoManuel R Teixeira
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrícia M MachadoFátima Vaz
Sep 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R FerlaA Russo
Jul 3, 2007·BMC Medical Genetics·Sandra FilippiniAna Vega
Oct 10, 2007·Archives of Neurology·Sandra MartinsJorge Sequeiros
Nov 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Orland DíezGemma Llort
Nov 24, 2007·Nature Reviews. Cancer·James D Fackenthal, Olufunmilayo I Olopade
Mar 26, 2008·Breast Cancer Research and Treatment·Ana PeixotoManuel R Teixeira
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Oct 15, 2008·Breast Cancer Research and Treatment·Ana PeixotoManuel R Teixeira
Jan 6, 2009·Familial Cancer·Catarina SantosManuel R Teixeira
Apr 21, 2010·Cell·Jon McClellan, Mary-Claire King
Citations
Jul 20, 2011·Breast Cancer Research and Treatment·Mads ThomassenAna Vega
Sep 24, 2011·BMC Medical Genetics·Danièle MullerJoseph Abecassis
Apr 2, 2014·PloS One·Laura FachalAna Vega
Jul 26, 2012·Familial Cancer·Miguel A M MoreiraFernando R Vargas
Feb 20, 2013·Human Mutation·Sylvia De BrakeleerErik Teugels
Jun 12, 2014·Clinical Genetics·A PeixotoM R Teixeira
Dec 1, 2015·PloS One·Diego Davila PaskulinPatricia Ashton-Prolla
Sep 17, 2014·Hereditary Cancer in Clinical Practice·Taila HartleyWilliam D Foulkes
Aug 18, 2016·PloS One·Pedro PintoManuel R Teixeira
Aug 25, 2016·Breast Cancer Research and Treatment·Pedro PintoManuel R Teixeira
Jun 16, 2016·Genetics and Molecular Biology·Ingrid Petroni EwaldPatricia Ashton-Prolla
Apr 26, 2014·Genetics and Molecular Biology·Patricia Ashton-Prolla, Fernando Regla Vargas
Jan 28, 2017·Hereditary Cancer in Clinical Practice·Marcia Cruz-CorreaUNKNOWN Puerto Rico Clinical Cancer Genetics Consortia
Mar 11, 2020·JCO Global Oncology·Maria Isabel AchatzPatricia Ashton-Prolla
May 1, 2018·Oncotarget·Sandrine M CaputoEtienne Rouleau
Sep 29, 2018·Global Health, Epidemiology and Genomics·A AbbadF Radouani
Nov 8, 2018·Cancers·Hector J Diaz-ZabalaJulie Dutil
Feb 20, 2020·Reproductive Biology and Endocrinology : RB&E·Xiaofu ZhangJing Qu
May 18, 2017·European Journal of Human Genetics : EJHG·Louise CrivelliMichel Longy
May 4, 2021·Frontiers in Genetics·Tímea PóczaAnikó Bozsik